创新的降脂策略:基于RNA,小分子和蛋白质的疗法
Youngwoo Jang1, Eun-Jung Rhee2, Sung Hee Choi3
1Division of Cardiology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Endocrinology and metabolism (Seoul, Korea)
|November 10, 2025
概括
创新疗法为治疗脱脂症和降低动脉样硬化心血管疾病 (ASCVD) 风险提供了新的希望. 这些先进的治疗方法针对具有挑战性的脂质标,如脂蛋白和甘油三,改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 失脂症是动脉样硬化心血管疾病 (ASCVD) 的一个关键可修改的风险因素.
- 尽管使用了他类药物和其他疗法,但仍然存在显著的残留风险,原因是低密度脂蛋白胆固醇 (LDL-C) 降低不足,高甘油三和高脂蛋白 (Lp) 等因素.
研究的目的:
- 审查超越传统药物的新型降脂疗法.
- 总结ASCVD预防新兴治疗方法的机制,临床试验和影响.
主要方法:
- 审查最近在降脂疗法方面的进展.
- 分析小分子,单克隆抗体,蛋白质注入和基于RNA的策略.
- 对向PCSK9,ANGPTL3,C-III,B,CETP和Lp的药物进行检查.
主要成果:
- 新的药物显示出强大的脂质调节,提高了安全性和方便性.
- 在临床试验中,佩多酸,PCSK9抑制剂和icosapent ethyl已经显示出有效性.
- 目前正在进行的药物试验包括obicetrapib,口服PCSK9抑制剂,Lp(a) 向的寡核酸和ANGPTL3导向的RNA疗法.
结论:
- 创新的治疗方法有望显著改变ASCVD预防策略.
- 这些先进的治疗方法解决了管理复杂脂质失调症的未满足需求.
- 未来的治疗算法可能会将这些新型药物纳入全面的脂质管理中.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:26Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
02:30siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
02:30Small interfering RNAs (siRNA)
4.2K
4.2K
01:23RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K